Literature DB >> 6471900

Aetiologic factors in lymphoid malignancies: a case-control epidemiological study.

S M Bernard, R A Cartwright, C C Bird, I D Richards, I Lauder, B E Roberts.   

Abstract

A prospective case-control study of the aetiologic factors involved in the production of lymphoid malignancies has been conducted within a defined geographical area covering six health districts in the Yorkshire Region. Among the aspects investigated were past medical events, occupations and certain social factors. A number of possible causal relationships have been identified including Jewish religion, past solvent exposure and ingestion of amphetamines, although the latter did not achieve statistical significance in this study. In addition several new associations have been identified, most notably with the occurrence of adult eczema/dermatitis and with treatment by radiation or steroids. The feasibility of conducting such a broadly based epidemiological investigation has been established.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6471900     DOI: 10.1016/0145-2126(84)90016-x

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  14 in total

1.  Association of asthma with the risk of acute leukemia and non-Hodgkin lymphoma.

Authors:  Min-Hang Zhou; Qing-Ming Yang
Journal:  Mol Clin Oncol       Date:  2015-05-11

2.  Farming and malignant lymphoma in Hancock County, Ohio.

Authors:  R Dubrow; J O Paulson; R W Indian
Journal:  Br J Ind Med       Date:  1988-01

3.  Haematopoietic cancer and medical history: a multicentre case control study.

Authors:  P Vineis; P Crosignani; C Sacerdote; A Fontana; G Masala; L Miligi; O Nanni; V Ramazzotti; S Rodella; E Stagnaro; R Tumino; C Viganò; C Vindigni; A S Costantini
Journal:  J Epidemiol Community Health       Date:  2000-06       Impact factor: 3.710

4.  Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.

Authors:  Claire M Vajdic; Michael O Falster; Silvia de Sanjose; Otoniel Martínez-Maza; Nikolaus Becker; Paige M Bracci; Mads Melbye; Karin Ekström Smedby; Eric A Engels; Jennifer Turner; Paolo Vineis; Adele Seniori Costantini; Elizabeth A Holly; Eleanor Kane; John J Spinelli; Carlo La Vecchia; Tongzhang Zheng; Brian C-H Chiu; Luigino Dal Maso; Pierluigi Cocco; Marc Maynadié; Lenka Foretova; Anthony Staines; Paul Brennan; Scott Davis; Richard Severson; James R Cerhan; Elizabeth C Breen; Brenda Birmann; Wendy Cozen; Andrew E Grulich
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

Review 5.  Meta-analysis of benzene exposure and non-Hodgkin lymphoma: biases could mask an important association.

Authors:  C Steinmaus; A H Smith; R M Jones; M T Smith
Journal:  Occup Environ Med       Date:  2008-04-16       Impact factor: 4.402

Review 6.  The US FDA 'black box' warning for topical calcineurin inhibitors: an ongoing controversy.

Authors:  Johannes Ring; Matthias Möhrenschlager; Verena Henkel
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

7.  Noncutaneous and Cutaneous Cancer Risk in Patients With Atopic Dermatitis: A Systematic Review and Meta-analysis.

Authors:  Lily Wang; Rachel Bierbrier; Aaron M Drucker; An-Wen Chan
Journal:  JAMA Dermatol       Date:  2020-02-01       Impact factor: 10.282

8.  The inter-regional epidemiological study of childhood cancer (IRESCC): a case control study of aetiological factors in leukaemia and lymphoma.

Authors:  P A McKinney; R A Cartwright; J M Saiu; J R Mann; C A Stiller; G J Draper; A L Hartley; P A Hopton; J M Birch; J A Waterhouse
Journal:  Arch Dis Child       Date:  1987-03       Impact factor: 3.791

9.  Exploring risk factors for follicular lymphoma.

Authors:  Alexander J Ambinder; Pareen J Shenoy; Neha Malik; Alison Maggioncalda; Loretta J Nastoupil; Christopher R Flowers
Journal:  Adv Hematol       Date:  2012-09-18

10.  Rising incidence of lymphoid malignancies--true or false?

Authors:  N Barnes; R A Cartwright; C O'Brien; I D Richards; B Roberts; C C Bird
Journal:  Br J Cancer       Date:  1986-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.